Fresenius Medical Care Balboa LLC is categorized under Kidney Dialysis Centers in Waltham, MA and active since 2008.
Fresenius Medical Care Balboa LLC was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.
If you are seeking more information, feel free to contact Mary Garber at the company’s headquarters by writing to 920 Winter St, Waltham, Massachusetts MA 02451 or by phoning (781) 699-4404. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fresenius Medical Care Balboa LLC |
| Contact Person: | Mary Garber |
| Address: | 920 Winter St, Waltham, Massachusetts 02451 |
| Phone Number: | (781) 699-4404 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2008 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Kidney Dialysis Centers |
| SIC Code: | 8092 |
| NAICS Code: | 621492 |
| Share This Business: |
Fresenius Medical Care Balboa LLC was started in 2008 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Mary Garber for inquiries that concern Fresenius Medical Care Balboa LLC by calling the company number (781) 699-4404, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Fresenius Medical Care Balboa LLC can be found at the coordinates 42.40956,-71.273735 as well as the street address 920 Winter St in Waltham, Massachusetts 02451.
For its online presence, you may visit Fresenius Medical Care Balboa LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.